tradingkey.logo

Sartorius Stedim Biotech Signs MoU With Sensible Biotechnologies On Cell-Based mRNA Production

ReutersJul 9, 2025 1:04 PM

- Sartorius Stedim Biotech SA STDM.PA:

  • SIGNS MOU WITH SENSIBLE BIOTECHNOLOGIES TO ADVANCE CELL-BASED MRNA PRODUCTION

  • COLLABORATION AIMS TO ENABLE CLINICAL-GRADE PRODUCTION OF CELL-BASED MRNA BY 2026

Source text: here

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI